Losartan Potassium Tablet, Film Coated
Product Images NDC 68382-137

8 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 68382-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)
Chemical structure of Losartan Potassium, showing the molecular arrangement with potassium ion (K+) and various chemical groups consistent with the active ingredient Losartan Potassium.*
FDA Label Image

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)
A line graph comparing the percentage of patients with primary endpoints over a 66-month study period between Atenolol (dashed line) and Losartan Potassium (solid line). The graph shows adjusted risk reduction of 13% for Losartan Potassium with a p-value of 0.021.*
FDA Label Image

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)
A line graph comparing the percentage of patients experiencing fatal or non-fatal stroke over study months treated with Atenolol (dashed line) versus Losartan Potassium (solid line). The graph shows cumulative incidence over approximately 66 months with a noted adjusted risk reduction of 25% for Losartan Potassium (p=0.001).*
FDA Label Image

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)
A forest plot chart comparing Losartan Potassium and Atenolol event rates in patient subgroups for primary composite and stroke (fatal/non-fatal) outcomes. It shows hazard ratios with 95% confidence intervals across age, gender, race, ischemic heart disease, diabetes, and cardiovascular disease history categories among 9193 patients.*
FDA Label Image

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)
A line graph comparing the percentage of patients experiencing an event over a 48-month period between those taking Losartan Potassium tablets and those taking a placebo. The graph shows a lower cumulative event rate for Losartan Potassium compared to placebo, with a reported risk reduction of 16.1% and a p-value of 0.022.*
FDA Label Image

Losapotataba (6cc1d73f 0d63 43bc A54c 6c2295338016 06)

Losapotataba (6cc1d73f 0d63 43bc A54c 6c2295338016 06)
Label for Losartan Potassium Tablets USP 25 mg by Zydus Pharmaceuticals USA Inc. The label indicates oral film-coated tablets, with 30 tablets per bottle for prescription use. Storage and safety instructions including child resistance, room temperature storage, and keeping the medicine out of children's reach are also provided.*
FDA Label Image

Losapotatabb (6cc1d73f 0d63 43bc A54c 6c2295338016 07)

Losapotatabb (6cc1d73f 0d63 43bc A54c 6c2295338016 07)
Losartan Potassium 50 mg Tablets, USP film-coated oral tablets. The label indicates 30 tablets per package, prescription use only. Manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals USA Inc. Storage instructions and warnings about child-resistant packaging and protection from light are also included on the label.*
FDA Label Image

Losapotatabc (6cc1d73f 0d63 43bc A54c 6c2295338016 08)

Losapotatabc (6cc1d73f 0d63 43bc A54c 6c2295338016 08)
Losartan Potassium Tablets, USP 100 mg film-coated tablet label. The label includes the NDC 68382-137-06, indicates a package of 30 tablets for prescription use only. Manufactured by Zydus Lifesciences Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. Storage instructions, dosage caution, and child-resistant packaging information are provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.